Tetrahydropalmatine (hydrochloride)

Tetrahydropalmatine (DL-Tetrahydropalmatine) hydrochloride possesses analgesic effects. Tetrahydropalmatine hydrochloride acts through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats[1].

Product Specifications

CAS Number

[6024-85-7]

Product Name Alternative

DL-Tetrahydropalmatine (hydrochloride)

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Dopamine Receptor

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Purity

99.91

Solubility

DMSO : 25 mg/mL (ultrasonic) |H2O : 4 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

COC1=CC=C2C(CN3CCC4=CC(OC)=C(OC)C=C4C3C2)=C1OC.[H]Cl

Molecular Formula

C21H26ClNO4

Molecular Weight

391.89

Precautions

H315, H319, H335

References & Citations

[1]Chang CK, et al. DL-Tetrahydropalmatine may act through inhibition of amygdaloid release of dopamine to inhibit an epileptic attack in rats. Neurosci Lett. 2001 Jul 20;307 (3) :163-6.